Key facts
- Sware’s last known valuation is $20.0M (Apr 2024).
- It has raised $26.2M; the latest was Later Stage VC in Oct 2025.
- Notable investors include Right Side Capital Management, Insight Partners (New York), First Analysis, Jumpstart Capital (Tennessee), Jumpstart Foundry — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Sware
- ·The full record, as it builds
Funding rounds
No funding rounds for Sware are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Sware
Developer of a validation automation platform designed for regulated systems compliance. The company's platform offers a lifecycle management system that automates compliance processes, including testing, release management, and regulatory adherence through workflow automation, audit tracking, and risk assessment tools, enabling life sciences organizations to streamline validation procedures, reduce operational inefficiencies, and maintain regulatory standards without manual intervention.
- Sector
- Information Technology
- HQ
- Boston, MA, United States
- Founded
- 2015
- Employees
- 69
- Website
- sware.com/
- Ownership
- Privately Held (backing)
Sware doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Sware shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Sware in its N-PORT filings yet. We sweep new filings monthly.